Bemis Co Inc (BMS) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. Bemis Co Inc operates in the packaging industry. The company engages in the manufacture of packaging ...
Shares in Bristol-Myers Squibb were given a nudge after US regulators accepted an application to expand the use of its immunotherapy Opdivo in lung cancer. Shares in Bristol-Myers Squibb were given a ...
Bristol-Myers Squibb (BMS) has filed for approval of a fixed-dose combination of its HIV drug Reyataz with Gilead Sciences’ cobicistat in the US. The product combines BMS’ successful HIV protease ...
Bristol-Myers Squibb’s drive to build its Opdivo immunotherapy franchise continues, this time with a new FDA filing to treat melanoma in an earlier setting. BMS has asked the FDA for a licence to ...
Bristol-Myers Squibb’s drive to build its Opdivo immunotherapy franchise continues, this time with a new FDA filing to treat melanoma in an earlier setting. BMS has asked the FDA for a licence to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results